|
| Article Access Statistics | | | Viewed | 5353 | | | Printed | 139 | | | Emailed | 0 | | | PDF Downloaded | 657 | | | Comments | [Add] | | | Cited by others | 14 | | |
|
Click on image for details.
|
|
|
|
| Year : 2019
| Volume
: 12 | Issue : 1 | Page
: 38-44 |
|
| Outcome of pediatric cardiac surgery and predictors of major complication in a developing country |
|
|
Indah K Murni1, Mulyadi M Djer2, Piprim B Yanuarso2, Sukman T Putra2, Najib Advani2, Jusuf Rachmat3, Aries Perdana4, Rubiana Sukardi5
1 Department of Pediatrics, Faculty of Medicine, Dr. Sardjito Hospital, Universitas Gadjah Mada, Yogyakarta, Indonesia
2 Department of Child Health, Dr. Cipto Mangunkusumo Hospital, University of Indonesia, Jakarta, Indonesia
3 Department of Cardio-Thoracic Surgery, Dr. Cipto Mangunkusumo Hospital, University of Indonesia, Jakarta, Indonesia
4 Department of Anesthesiology, Dr. Cipto Mangunkusumo Hospital, University of Indonesia, Jakarta, Indonesia
5 Integrated Cardiac Centre, Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia
Click here for correspondence address and
email
| Date of Web Publication | 14-Jan-2019 |
|
|
 |
|
 Abstract | | |
Background: Evaluating outcome and identifying predictors of major complications among children undergoing cardiac surgery are essential to improve care. We evaluated short-term outcomes of postcardiac surgery and predictors of major complications in a national referral hospital in Indonesia.
Methods: A prospective cohort study was conducted from April 2014 to March 2015 on all children undergoing cardiac surgery. Participants were followed up from the time of surgery until hospital discharge and 30-day mortality. We performed univariate and multivariate logistic regression using STATA 12-1 to identify predictors of postsurgical major complications.
Results: A total of 257 patients (median age: 36 months) were recruited; 217 (84.1%) had complications, including low cardiac output syndrome (19.8%), arrhythmia (18.6%), sepsis (17.4%), and pleural effusion (14.8%). Forty-nine (19%) patients had major complications, including cardiac arrest (5%), need for emergency chest opening (3.9%), and multiple organ failure (7.4%). 12.8% died during hospital stay, and 30-day mortality was 13.6%. Predictors of major complications were cyanotic congenital heart disease (odds ratio [OR]: 4.6, 95% confidence interval [CI]: 1.5–14.2), longer duration of cardiopulmonary bypass (CPB, OR: 4.4, 95% CI: 1.5–13.4), high inotropes (OR: 13.1, 95% CI: 3.2–54.2), and increase in lactate >0.75 mmol/L/h or more in the first 24 h (OR: 37.1, 95% CI: 10.1–136.3).
Conclusion: One-fifth of children undergoing cardiac surgery experienced major complications with around 13% mortality. Cyanotic congenital heart disease, longer duration of CPB, high inotropes on leaving operating theater, and increase in blood lactate are associated with major complications in children after cardiac surgery.
Keywords: Cardiac surgery, children, complication, mortality, outcome, predictor
How to cite this article:
Murni IK, Djer MM, Yanuarso PB, Putra ST, Advani N, Rachmat J, Perdana A, Sukardi R. Outcome of pediatric cardiac surgery and predictors of major complication in a developing country. Ann Pediatr Card 2019;12:38-44 |
How to cite this URL:
Murni IK, Djer MM, Yanuarso PB, Putra ST, Advani N, Rachmat J, Perdana A, Sukardi R. Outcome of pediatric cardiac surgery and predictors of major complication in a developing country. Ann Pediatr Card [serial online] 2019 [cited 2023 Jan 27];12:38-44. Available from: https://www.annalspc.com/text.asp?2019/12/1/38/250146 |
| Introduction | |  |
The performance of pediatric cardiac surgery programs should be continually evaluated to improve the quality of patient care.[1] Outcomes of pediatric cardiac surgery are well described in high-income countries; however, data from low-to-middle-income countries have been limited. Mortality has been used as a robust indicator to evaluate the quality of pediatric cardiac surgery care.[2] However, morbidities or complications after cardiac surgery may serve an additional indicator to determine the quality of cardiac surgical services.[2]
In low-to-middle-income countries, limitations of human resources and facilities for cardiac surgery and postoperative management may adversely affect the outcomes of the pediatric cardiac surgery. Major complications are often preceded by a period of inadequate oxygen balance, and identifying the oxygen imbalance is challenging in children after cardiac surgery.[3],[4] Therefore, knowing the predictors for major complication is important to formulate a preventive strategy for major complications after cardiac surgery and to improve care. Given limited data, studies are needed to identify predictors for adverse outcomes of pediatric cardiac surgery performed. This study aimed to evaluate the outcomes and predictors for major complications in children undergoing cardiac surgery as initial problems at a national referral hospital of cardiac service in Indonesia.
| Methods | | |
Study design and population
A prospective cohort study was conducted in cardiac intensive care unit (CICU), Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia, between April 2014 and March 2015. Dr. Cipto Mangunkusumo National General Hospital is the national referral hospital in Indonesia. The CICU is an 8-bed unit providing postoperative care for both adult and pediatric patients and is managed by intensivist and pediatric cardiac intensivist. There are two pediatric cardiac surgeons in this hospital. The hospital started working on pediatric cardiac care in 2002. This study had been approved by the Ethics Committee of the University of Indonesia, Jakarta, Indonesia. The ethics committees did not require individual patient consent, but all parents of children in the ward were informed of the study.
We consecutively enrolled pediatric patients admitted to CICU after cardiac surgery for both congenital and acquired heart diseases. All participating children were monitored daily from the time of surgery performed until they were discharged or died to identify the presence of complication after cardiac surgery. Complications were defined based on the multisocietal database committee for pediatric and congenital heart disease criteria.[5] Factors associated with the development of major complications were identified.
Data collection
We collected data using a standardized form to record major complications, which included death, multiorgan dysfunction, cardiac arrest, and need for emergency chest opening. We also recorded baseline characteristics of patients, clinical signs or symptoms, the outcomes of cardiac surgery, and potential predictors of major complications after surgery. Risk Adjustment for Congenital Heart Surgery-1 (RACHS-1) category was used to compare outcome data for children undergoing cardiac surgery.
Five potential predictors were included as follow: preoperative congestive heart failure, cyanotic congenital heart disease, longer duration of cardiopulmonary bypass (CPB) (>120 min), high inotropic drug requirement on discharge from operating room, and increase in blood lactate level (>0.75 mmol/L/h or more in the first 24 h after cardiac surgery).[3],[6] High inotropic drug requirement was defined as the use of at least two types of drugs with high doses (≥10 mcg/kg/min of dopamine or dobutamine, or epinephrine or norepinephrine at least 0.1 mcg/kg/min, or milrinone at least 0.5 mcg/kg/min).
Outcome measures
We set inhospital mortality, 30-day mortality, and the incidence of complications including major complications after cardiac surgery as the primary outcomes. A 30-day mortality was defined when death occurred outside of the hospital but within 30 days after cardiac surgery performed. Complication was defined as a deviation from the expected outcome of cardiac surgery.[7] In addition, we secondarily looked at factors to predict the development of major complications after pediatric cardiac surgery in children in Indonesia.
Data analysis
We first described baseline data and outcomes using mean, median, or proportions as appropriate. We first performed univariate analysis using the Chi-square test to determine the association between each predictor and the occurrence of major complications. We further conducted a multivariate logistic regression to determine predictors which were independently associated with major complications after cardiac surgery. All potential predictors, including all variables found to be statistically significant on the univariable analysis, were included in the multivariable model. Findings are presented as odds ratios with corresponding 95% confidence intervals (CIs) and P values. The Hosmer–Lemeshow test was used to check for goodness of fit for logistic regression model.
Data analysis was performed using STATA version 12.1, StataCorp LP, College Station, Texas, USA. P <0.05 or a CI not including 1 was considered as statistically significant.
| Results | | |
Two hundred and fifty-seven patients were enrolled. Their baseline characteristics are described in [Table 1]. Most patients were undernourished and about half had failure to thrive. The most common congenital heart operation performed was ventricular septal defect (VSD) repair (28.7%), and the most common cyanotic congenital heart disease surgery was for tetralogy of Fallot (TOF) repair, which comprised 24.4% of the total procedures. The majority of patients who underwent definitive cardiac surgery were included in the RACHS-1 category 2 (84.4%). Approximately more than 10% of children had long duration of mechanical ventilation (>7 days) and hospital stay (>14 days) [Table 2].
Most patients (84.1%) experienced some postoperative complications. The most common complication was hypocalcemia (63%), hyperglycemia (61.5%), low cardiac output syndrome (LCOS) (19.8%), arrhythmia (18.6%), nosocomial bloodstream infections or sepsis (17.4%), and pleural effusion (14.8%) [Table 3]. Around 13% of all blood cultures obtained were positive and the causes of nosocomial bloodstream infections were mostly Gram-negative bacteria including Acinetobacter baumannii, Escherichia More Details coli, and Klebsiella pneumoniae. The incidences of postoperative arrhythmia and total atrioventricular (AV) block in our cohort were 18.6 and 5.8%, respectively.
About one-fifth (19%) developed at least one major complication after cardiac surgery during the follow-up. In-hospital mortality occurred in 33 (12.8%) and a 30-day mortality in 35 (13.6%) children after cardiac surgery [Table 4]. Two patients died within 30 days after cardiac surgery outside the hospital, including a patient with congenitally corrected transposition of the great arteries (TGAs) undergoing bidirectional cavopulmonary shunt (BCPS), and one patient following repair of complete atrio ventricular septal defect (CAVSD). The possible causes of death were recurrent massive pleural effusion in the patient after BCPS procedure and total AV block in the patient with CAVSD repair. | Table 4: Proportion of major complications after pediatric cardiac surgery
Click here to view |
We evaluated five potential predictors to predict major complications after cardiac surgery among these children. The univariate analysis identified that all predictors were significantly associated with the development of major complications. In the multivariate logistic regression analysis, cyanotic congenital heart disease, longer duration of CPB, high inotropic drugs on leaving operating room, and increased blood lactate level were independently associated with the development of major complications after cardiac surgery. Cyanotic congenital heart disease and longer duration of CPB were associated with around 4-fold higher risk in the probability of developing major complications, while high inotropic drugs on discharge from operating theater and increased blood lactate level were independently associated with around 13- and 30-fold increased risk, respectively [Table 5]. | Table 5: Predictors of major complications after pediatric cardiac surgery
Click here to view |
| Discussions | | |
As far as we are aware, this study was the first study in Indonesia evaluating the outcomes of children after cardiac surgery, demonstrating an inhospital mortality of 12.8%. Mortality rates after surgery differ markedly depending on the complexity and severity of cases attempted, comorbidities (such as malnutrition and chronic infections), as well as the quality of surgery and postoperative care.[8]
A study in other developing countries found mortality of similar or lower levels to us: Iran (12.4%),[9] Guatemala (10.7%),[10] India (7.9%),[11] and China (5.5%).[12] In large pediatric cardiac services in high-income countries, mortality after cardiac surgery in children has been reported to be <5%.[13] There is an inverse relationship between volume of cardiac surgery performed and mortality. Compared with units that perform more than 300 operations annually, units with around 101 cases/year were associated with increased mortality of 3-fold, whereas those with <10 cardiac surgery cases per year were associated with an 8-fold increased mortality.[14] In addition, the surgeons should recognize a learning curve when undertaking new surgical procedure. Introduction of a new procedure using training courses and expert assistance might reduce the learning curve.[15]
The 30-day mortality rate in our study was 13.6%. The highest mortality among our patients occurred in those undergoing an arterial switch operation for TGA with VSD and TGA with intact ventricular septum. In our study, the most common cause for mortality was pulmonary hypertension, which often resulted from delayed timing of surgery associated with late presentations of children with congenital heart diseases. Most patients who died after arterial switch operation mostly suffered from pulmonary hypertensive crisis, which is challenging to deal with in setting with limited resources.
The incidence of complications in our patients was as high as 81%, which was relatively high compared to previously published studies. This may be caused by different definitions of complications, in which we included endocrine complications after cardiac surgery, such as hypocalcemia, hyperglycemia, and hypoglycemia, which were rarely accounted in previous studies as such complications could physiologically occur after cardiac surgery using CPB. Hyperglycemia and hypocalcemia occurred in >60% patients after cardiac surgery in our study. This was similar to findings reported by other studies in developing countries.[16],[17] When we excluded the endocrine complication, the incidence of complication after cardiac surgery in our patients decreased to 44%. The most complications occurring after cardiac surgery were LCOS, arrhythmia, nosocomial sepsis, and pleural effusion.
Finding from this study shows that the incidence of LCOS was similar to other studies, which was 25%–32% in patients after cardiac surgery.[18] The management of children after cardiac surgery includes avoiding factors contributed to the development of LCOS. These include maintaining adequate preload, using vasoactive drugs to improve contractility, and maintaining systemic and pulmonary vascular resistance.[7],[18] In our hospital, when managing LCOS, we used inotropic and inodilator drugs simultaneously including dopamine, epinephrine, norepinephrine, and milrinone.
Total AV block occurred in 5.8% patients after TOF correction, CAVSD repair, and VSD closure. This is in accordance with a previous study that total AV block commonly occurred in patients with TOF, CAVSD, and VSD as the conduction system located along those defects, which had injured.[19]
Another frequent postoperative complication is nosocomial bloodstream infections or sepsis, which occurred in 17.4% children after cardiac surgery. This incidence is much higher compared to a previous study, which only found 8.6% patients suffered from nosocomial sepsis.[20] Gram-negative sepsis is prevalent in children with postoperative bloodstream infections in low-to-middle-income countries and is associated with significant morbidity, higher mortality, and development of antibiotic resistance. Practical steps can be taken to make surgery safer since good nutrition, early corrective surgery, and measures to reduce nosocomial infection are likely to play a role.[21]
We identified factors predicting the development of major complications after cardiac surgery to guide further preventative strategies. Predictors for developing major complications in our study were cyanotic congenital heart disease, longer duration of CPB, high inotropic drugs on leaving operating theater, and increase in blood lactate.
In patients with cyanotic congenital heart disease, especially those suffering from complex heart lesions usually need longer surgery and CPB time because of higher surgical complexity. They might suffer from severe metabolic acidosis and tissue hypoxemia, which is likely to predispose them for mortality.[9] The presence of cyanotic congenital heart disease is an intrinsic factor that cannot be controlled in increasing the risk of developing major complications after cardiac surgery, but it can raise awareness to mitigate harmful outcomes.
The use of high inotropes on leaving operating room was associated with mortality and cardiac arrest in children after cardiac surgery. The more severe the hemodynamic state, the lower the cardiac index, and therefore, higher inotropic support was needed.[22]
Increase in blood lactate could reflect the presence of anaerobic metabolism, which is caused by inadequate oxygenation, reduced oxygen delivery, or cellular hypoxia. Increase in blood lactate >0.75 mmol/L can predict early outcome of neonates after cardiac surgery with high specificity[6] but low sensitivity since this might physiologically reflect hyperlactatemia after CPB and impaired lactate clearance.[4]
This finding highlights the need for comprehensive interventions to improve the quality of pediatric cardiac surgery services and reduce mortality and other major complications among children after cardiac surgery by preventing the occurrence of clinical conditions that required longer CPB, high inotropes, and caused increase in blood lactate after cardiac surgery.
Some facts in developing world related to cardiac surgery program include competing priorities, poor structural organizations, lack of financial resources, lack of trained human resources, and absence of stable training and education infrastructure.[13] These require an effective policy response to make efforts for improving quality of cardiac surgery program in such low-to-middle-income countries. Attempts should be conducted earlier before the actual implementation of the cardiac surgery and critical care program. These include training in pediatric cardiac surgery and critical care in low-and-middle-income countries from well-established pediatric cardiac center program in high-income countries. In addition, a model of mentoring physicians and other staff from well-established centers to establish high-quality referral and cardiac training centers in low-to-middle-income countries is needed. Furthermore, a member of subspecialties from low-and-middle-income countries should visit a well-established cardiac center to observe the unit or participate in overseas training or education programs.[23],[24],[25],[26]
Limitation of this study is that this study was performed in a single national referral hospital and therefore may not represent the status of other hospitals in Indonesia. Howeverare it is likely that practices in Jakarta are not so different from other referral hospitals which provide pediatric cardiac surgery services. To be generalizable, this study should be reproduced in other tertiary referral hospitals in Indonesia and other low-to-middle-income countries. Other limitations are lactate clearance time, and venous oxygen saturation (SvO2) was not measured routinely in conjunction with blood lactate examination after cardiac surgery. A SvO2 may suggest different pathophysiology of tissue hypoxia compared to lactate.[4] An abnormality in SvO2 could be present without an abnormality in blood lactate and therefore might explain small changes in lactate and improve the accuracy of blood lactate in predicting major complications after cardiac surgery.[4]
| Conclusion | | |
Approximately one-fifth of children undergoing cardiac surgery at a national referral hospital in Indonesia had major adverse events and around 13% died. Cyanotic congenital heart disease, longer duration of CPB, high inotropes on leaving operating room, and increase in blood lactate were associated with increased risk of mortality and developing other major complications in children after cardiac surgery.
Acknowledgment
We gratefully acknowledge Prof. Trevor Duke and Dr. Nikmah S Idris for providing the editorial assistance.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
| References | | |
| 1. | Eghtesady P, Brar AK, Hall M. Prioritizing quality improvement in pediatric cardiac surgery. J Thorac Cardiovasc Surg 2013;145:631-9.  |
| 2. | Welke KF, Ungerleider RM. Mortality as an outcome parameter for pediatric heart surgery. ASAIO J 2006;52:552-5. |
| 3. | Duke T, Stocker C, Butt W. Monitoring children after cardiac surgery: A minimalist approach might be maximally effective. Crit Care Resusc 2004;6:306-10. |
| 4. | Duke T, Butt W, South M, Karl TR. Early markers of major adverse events in children after cardiac operations. J Thorac Cardiovasc Surg 1997;114:1042-52. |
| 5. | Part IV. The dictionary of definitions of complications associated with the treatment of patients with congenital cardiac disease. Cardiol Young 2008;18 Suppl 2:282-530. |
| 6. | Charpie JR, Dekeon MK, Goldberg CS, Mosca RS, Bove EL, Kulik TJ, et al. Serial blood lactate measurements predict early outcome after neonatal repair or palliation for complex congenital heart disease. J Thorac Cardiovasc Surg 2000;120:73-80. |
| 7. | Gazit AZ, Huddleston CB, Checchia PA, Fehr J, Pezzella AT. Care of the pediatric cardiac surgery patient-Part 1. Curr Probl Surg 2010;47:185-250. |
| 8. | Tefuarani N, Vince J, Hawker R, Sleigh A, Williams G. The medium-to-long-term outcome of Papua New Guinean children after cardiac surgery. Ann Trop Paediatr 2004;24:65-74. |
| 9. | Roodpeyma S, Hekmat M, Dordkhar M, Rafieyian S, Hashemi A. A prospective observational study of paediatric cardiac surgery outcomes in a postoperative intensive care unit in Iran. J Pak Med Assoc 2013;63:55-9. |
| 10. | Leon-Wyss JR, Veshti A, Veras O, Gaitán GA, O'Connell M, Mack RA, et al. Pediatric cardiac surgery: A challenge and outcome analysis of the Guatemala effort. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2009;12:8-11. |
| 11. | Joshi SS, Anthony G, Manasa D, Ashwini T, Jagadeesh AM, Borde DP, et al. Predicting mortality after congenital heart surgeries: Evaluation of the aristotle and risk adjustement in congenital heart surgery-1 risk prediction scoring systems: A retrospective single center analysis of 1150 patients. Ann Card Anaesth 2014;17:266-70. [ PUBMED] [Full text] |
| 12. | Ho TC, Ouyang H, Lu Y, Young AH, Chintala K, Detrano RC, et al. Postprocedural outcomes of rural children undergoing correction of congenital heart lesions in Yunnan Province, China. Pediatr Cardiol 2011;32:811-4. |
| 13. | Tchervenkov CI, Jacobs JP, Bernier PL, Stellin G, Kurosawa H, Mavroudis C, et al. The improvement of care for paediatric and congenital cardiac disease across the world: A challenge for the world society for pediatric and congenital heart surgery. Cardiol Young 2008;18 Suppl 2:63-9. |
| 14. | Gauvreau K. Reevaluation of the volume-outcome relationship for pediatric cardiac surgery. Circulation 2007;115:2599-601. |
| 15. | Hasan A, Pozzi M, Hamilton JR. New surgical procedures: Can we minimise the learning curve? BMJ2000;320:171-3. |
| 16. | Robertie PG, Butterworth JF 4 th, Prielipp RC, Tucker WY, Zaloga GP. Parathyroid hormone responses to marked hypocalcemia in infants and young children undergoing repair of congenital heart disease. J Am Coll Cardiol 1992;20:672-7. |
| 17. | Lou S, Ding F, Long C, Liu J, Zhao J, Feng Z, et al. Effects of peri-operative glucose levels on adverse outcomes in infants receiving open-heart surgery for congenital heart disease with cardiopulmonary bypass. Perfusion 2011;26:133-9. |
| 18. | Ascenzi JA, Kane PL. Update on complications of pediatric cardiac surgery. Crit Care Nurs Clin North Am 2007;19:361-9, v. |
| 19. | Anderson JB, Czosek RJ, Knilans TK, Meganathan K, Heaton P. Postoperative heart block in children with common forms of congenital heart disease: Results from the KID database. J Cardiovasc Electrophysiol 2012;23:1349-54. |
| 20. | Elella RA, Najm HK, Balkhy H, Bullard L, Kabbani MS. Impact of bloodstream infection on the outcome of children undergoing cardiac surgery. Pediatr Cardiol 2010;31:483-9. |
| 21. | Murni IK, MacLaren G, Morrow D, Iyer P, Duke T. Perioperative infections in congenital heart disease. Cardiol Young 2017;27:S14-S21. |
| 22. | Gaies MG, Jeffries HE, Niebler RA, Pasquali SK, Donohue JE, Yu S, et al. Vasoactive-inotropic score is associated with outcome after infant cardiac surgery: An analysis from the pediatric cardiac critical care consortium and virtual PICU system registries. Pediatr Crit Care Med 2014;15:529-37. |
| 23. | Nguyen N, Pezzella AT. Pediatric cardiac surgery in low-and middle-income countries or emerging economies: A continuing challenge. World J Pediatr Congenit Heart Surg 2015;6:274-83. |
| 24. | Nguyen N, Leon-Wyss J, Iyer KS, Pezzella AT. Paediatric cardiac surgery in low-income and middle-income countries: A continuing challenge. Arch Dis Child 2015;100:1156-9. |
| 25. | Rao SG. Pediatric cardiac surgery in developing countries. Pediatr Cardiol 2007;28:144-8. |
| 26. | Murni IK, Musa NL. The need for specialized pediatric cardiac critical care training program in limited resource settings. Front Pediatr 2018;6:59. |
Correspondence Address:
Dr. Indah K Murni
Department of Pediatrics, Faculty of Medicine, Dr. Sardjito Hospital, Universitas Gadjah Mada, Yogyakarta
Indonesia
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/apc.APC_146_17
[Table 1], [Table 2], [Table 3], [Table 4], [Table 5] |
|
| This article has been cited by | | 1 |
Risk factors of postoperative low cardiac output syndrome in children with congenital heart disease: A systematic review and meta-analysis |
|
| Peiying Wang, Cangcang Fu, Guannan Bai, Linbo Cuan, Xiaomin Tang, Chendi Jin, Hongchong Jin, Jihua Zhu, Chunhong Xie | | Frontiers in Pediatrics. 2023; 10 | | [Pubmed] | [DOI] | | | 2 |
Neutrophil Count as Atrioventricular Block (AVB) Predictor following Pediatric Heart Surgery |
|
| Tomasz Urbanowicz, Anna Olasinska-Wisniewska, Marcin Gladki, Michal Michalak, Mateusz Sochacki, Anita Weclewska, Dominika Zalas, Waldemar Bobkowski, Marek Jemielity | | International Journal of Molecular Sciences. 2022; 23(20): 12409 | | [Pubmed] | [DOI] | | | 3 |
Cardiac Arrest in Children Following Cardiac Surgery: A Scoping Review of Contributing Factors |
|
| Christine M. Riley, Lee D. Murphy, Christopher W. Mastropietro | | World Journal for Pediatric and Congenital Heart Surgery. 2022; 13(4): 475 | | [Pubmed] | [DOI] | | | 4 |
Gain in growth after surgical repair of congenital heart disease among children with Down syndrome |
|
| Nazmus Saquib, Anas Naser Al Sarraj, Baraa Tarek Ziad Oubaied, Ahmad Mamoun Rajab, Bana Nasser Agha, Jesmin Hossain, Abdulrahman Almazrou, Juliann Saquib | | American Journal of Medical Genetics Part A. 2021; | | [Pubmed] | [DOI] | | | 5 |
Delayed diagnosis in children with congenital heart disease: a mixed-method study |
|
| Indah K. Murni, Muhammad Taufik Wirawan, Linda Patmasari, Esta R. Sativa, Nadya Arafuri, Sasmito Nugroho, Noormanto | | BMC Pediatrics. 2021; 21(1) | | [Pubmed] | [DOI] | | | 6 |
Predictor factors of pulmonary hypertension in children with left-to-right shunting in acyanotic congenital heart disease |
|
| Weny Inrianto, Indah Kartika Murni, Ida Safitri | | Paediatrica Indonesiana. 2021; 61(3): 119 | | [Pubmed] | [DOI] | | | 7 |
Biomarkers in low cardiac output syndrome after open cardiac surgery in children |
|
| Reby Kusumajaya, Najib Advani, Piprim B. Yanuarso, Zulham Effendy | | Paediatrica Indonesiana. 2021; 61(4): 223 | | [Pubmed] | [DOI] | | | 8 |
Survival of Left-to-Right Shunt Repair in Children with Pulmonary Arterial Hypertension at a Tertiary Hospital in a Low-to-Middle-Income Country |
|
| Nadya Arafuri, Indah K. Murni, Nikmah S. Idris, Cuno S. P. M. Uiterwaal, Ary I. Savitri, Sasmito Nugroho, Noormanto Noormanto | | Global Heart. 2021; 16(1): 25 | | [Pubmed] | [DOI] | | | 9 |
Evaluation of a Ten-Year Team-Based Collaborative Capacity-Building Program for Pediatric Cardiac Surgery in Uzbekistan: Lessons and Implications |
|
| Seungheon Han, Sugy Choi, Jongho Heo, Jayoung Park, Woong-Han Kim | | Annals of Global Health. 2020; 86(1) | | [Pubmed] | [DOI] | | | 10 |
The impact of partial blood replacement on postoperative outcome for pediatric patients with cyanotic heart disease |
|
| Saleh Mohammad | | Journal of Cardiovascular Medicine and Cardiology. 2020; : 167 | | [Pubmed] | [DOI] | | | 11 |
Effect of Prophylactic Levosimendan on All-Cause Mortality in Pediatric Patients Undergoing Cardiac Surgery—An Updated Systematic Review and Meta-Analysis |
|
| Hongbai Wang, Qipeng Luo, Yinan Li, Liang Zhang, Xie Wu, Fuxia Yan | | Frontiers in Pediatrics. 2020; 8 | | [Pubmed] | [DOI] | | | 12 |
Risk factors for severe pulmonary regurgitation after repair of tetralogy of Fallot with transannular patch |
|
| Putria Rayani Apandi, Rubiana Sukardi, Mulyadi M. Djer, Piprim B. Yanuarso, Suprayitno Wardoyo | | Cardiology in the Young. 2020; 30(12): 1917 | | [Pubmed] | [DOI] | | | 13 |
Single Institution Experience With International Referrals for Pediatric Cardiac Surgery |
|
| Michael A. Rebolledo, T. K. Susheel Kumar, James B. Tansey, Bill Pickens, Jerry Allen, H. Jane Hanafin, Umar S. Boston, Christopher J. Knott-Craig | | World Journal for Pediatric and Congenital Heart Surgery. 2020; 11(6): 727 | | [Pubmed] | [DOI] | | | 14 |
Surgeries in Neonates and Small-Weight Babies With Congenital Heart Diseases: Challenges and Gratification |
|
| Anil Kumar Dharmapuram, Nagarajan Ramadoss, Vejendla Goutami, Sudeep Verma, Nanda Kishor Kumar Vuppali, Sandya Pallapotu, Rushita Torkadi | | Indian Journal of Clinical Cardiology. 2020; 1(2): 70 | | [Pubmed] | [DOI] | |
|
|
|
|
|
|
|
|
|
